{
  "type": "add_node",
  "timestamp": "2025-08-21T19:07:14",
  "processed": false,
  "inputs": {
    "source_article_id": "JASZ1XB3Z",
    "status": "rejected",
    "reject_category": "company",
    "reject_failure_cat": "industry_vertical"
  },
  "details": {
    "llm_topic_proposal_raw": {
      "motivation": "The article introduces Sethera Therapeutics, a biotech company whose new enzymatic macrocyclization platform could materially influence the peptide therapeutics market, warranting a dedicated company node for analysis.",
      "id": "sethera_therapeutics",
      "name": "Sethera Therapeutics",
      "type": "company",
      "level": "main"
    },
    "topic_category": {
      "category": "company",
      "motivation": "Sethera Therapeutics is a biotech company developing a novel enzymatic platform for peptide therapeutics, warranting a dedicated company node for analysis."
    },
    "relevance_gate": {
      "should_add": false,
      "reason": "Sethera Therapeutics is a biotech company, an industry vertical, not a macro driver or tradable asset.",
      "confidence": 0.95,
      "failure_category": "industry_vertical"
    }
  },
  "id": "none"
}